{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:34:51Z","timestamp":1795023291079,"version":"4.10.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic foot is a significant cause of morbidity in diabetic patients, with a rate that is approximately twice that of patients without foot ulcers. \u201cMetabolic memory\u201d represents the epigenetic changes induced by chronic hyperglycaemia, despite the correction of the glucose levels themselves. These epigenetic modifications appear to perpetuate the damage caused by persistently elevated glucose levels even in their absence, acting at various levels, mostly affecting the molecular processes of diabetic ulcer healing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The aim of our cross-sectional study was to analyse a cohort of patients with diabetes with and without lower limb ulcers.<\/jats:p>\n                    <jats:p>We examined the effects of epigenetic changes on miRNA 126, 305, and 217 expression and the frequency of the SNPs of genes encoding inflammatory molecules (e.g., IL-6 and TNF-alpha) and their correlations with serum levels of proangiogenic molecules (e.g., ENOS, VEGF and HIF-1alpha) and several adipokines as well as with endothelial dysfunction, assessed noninvasively by reactive hyperaemia peripheral artery tonometry.<\/jats:p>\n                    <jats:p>Between March 2021 and June 2022, 110 patients were enrolled into the study: 50 diabetic patients with diabetic foot injuries, 40 diabetic patients without ulcerative complications and 20 nondiabetic patients as the control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Diabetic subjects with lower limb ulcerative lesions exhibited higher levels of inflammatory cytokines, such as VEGF (191.40\u2009\u00b1\u2009200\u00a0pg\/mL vs. 98.27\u2009\u00b1\u200956.92\u00a0pg\/mL vs. 71.01\u2009\u00b1\u200952.96\u00a0pg\/mL; p\u2009=\u20090.22), HIF-1alpha (40.18\u2009\u00b1\u200910.80\u00a0ng\/mL vs. 33.50\u2009\u00b1\u20096.16\u00a0ng\/mL vs. 33.85\u2009\u00b1\u20096.84\u00a0ng\/mL; p\u2009=\u20090.10), and Gremlin-1 (1.72\u2009\u00b1\u20090.512\u00a0ng\/mL vs. 1.31\u2009\u00b1\u20090.21\u00a0ng\/mL vs. 1.11\u2009\u00b1\u20090.19\u00a0ng\/mL; p\u2009&lt;\u20090.0005), than those without lower limb ulcers and healthy controls. Furthermore, we observed that miR-217-5p and miR-503-5p were 2.19-fold (p\u2009&lt;\u20090.05) and 6.21-fold (p\u2009=\u20090.001) more highly expressed in diabetic foot patients than in healthy controls, respectively. Additionally, diabetic patients without lower limb ulcerative complications showed 2.41-fold (p\u2009=\u20090) and 2.24-fold (p\u2009=\u20090.029) higher expression of miR-217-5p and miR-503-5p, respectively, than healthy controls. Finally, diabetic patients with and without ulcerative complications of the lower limbs showed higher expression of the VEGFC2578A CC polymorphism (p\u2009=\u20090.001) and lower expression of the VEGFC2578A AC polymorphism (p\u2009&lt;\u20090.005) than the healthy control population. We observed a significant increase in Gremlin-1 levels in patients with diabetic foot, suggesting that this inflammatory adipokine may serve as a predictive marker for the diagnosis of diabetic foot.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results highlighted that patients with diabetic foot showed predominant expression of the VEGF C2578A CC polymorphism and reduced expression of the AC allele. Additionally, we found an overexpression of miR-217-5p and miR-503-5p in diabetic patients with and without diabetic foot syndrome compared with healthy controls.<\/jats:p>\n                    <jats:p>These results align with those reported in the literature, in which the overexpression of miR-217-5p and miR-503-5p in the context of diabetic foot is reported. The identification of these epigenetic modifications could therefore be helpful in the early diagnosis of diabetic foot and the treatment of risk factors. However, further studies are necessary to confirm this hypothesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-023-01880-x","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T10:03:05Z","timestamp":1687773785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunction"],"prefix":"10.1186","volume":"22","author":[{"given":"Alessandro","family":"Del Cuore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria Maria","family":"Pipitone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Casuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Maria","family":"Mazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Puleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Pacinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Riolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Maida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Di Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Di Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Zito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Agnello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Di Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Ciaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Grimaudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Tuttolomondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"issue":"4","key":"1880_CR1","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/0002-9343(90)90492-V","volume":"88","author":"RD Abbott","year":"1990","unstructured":"Abbott RD, Brand FN, Kannel WB. Epidemiology of some peripheral arterial findings in diabetic men and women: experiences from the Framingham Study. Am J Med. 1990;88(4):376\u201381.","journal-title":"Am J Med"},{"issue":"5","key":"1880_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.metabol.2008.01.004","volume":"57","author":"A Pinto","year":"2008","unstructured":"Pinto A, Tuttolomondo A, Di Raimondo D, et al. Cardiovas-cular risk profile and morbidity in subjects affected by type 2 diabetes mellitus with and without diabetic foot. Metabolism. 2008;57(5):676\u201382.","journal-title":"Metabolism"},{"key":"1880_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1475-2840-9-50","volume":"9","author":"A Tuttolomondo","year":"2010","unstructured":"Tuttolomondo A, La Placa S, Di Raimondo D, et al. Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol. 2010;9:50.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1880_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12933-016-0483-5","volume":"16","author":"A Tuttolomondo","year":"2017","unstructured":"Tuttolomondo A, Casuccio A, Guercio G, Maida C, Del Cuore A, Di Raimondo D, Simonetta I, Di Bona D, Pecoraro R, Della Corte V, Gulotta E, Gulotta G, Pinto A. Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome. Cardiovasc Diabetol. 2017;16(1):2. https:\/\/doi.org\/10.1186\/s12933-016-0483-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"1880_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1161\/CIRCULATIONAHA.110.003855","volume":"123","author":"NJ Leeper","year":"2011","unstructured":"Leeper NJ, Cooke JP. MicroRNA and mechanisms of impaired angiogenesis in diabetes mellitus. Circulation. 2011;123(3):236\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.003855.","journal-title":"Circulation"},{"issue":"4","key":"1880_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jtv.2016.06.005","volume":"25","author":"S Jhamb","year":"2016","unstructured":"Jhamb S, Vangaveti VN, Malabu UH. Genetic and molecular basis of diabetic foot ulcers: clinical review. J Tissue Viability. 2016;25(4):229\u201336. https:\/\/doi.org\/10.1016\/j.jtv.2016.06.005. (Epub 2016 Jun 25 PMID: 27372176).","journal-title":"J Tissue Viability"},{"issue":"11","key":"1880_CR7","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s40618-019-01053-2","volume":"42","author":"CJ Lin","year":"2019","unstructured":"Lin CJ, Lan YM, Ou MQ, Ji LQ, Lin SD. Expression of miR-217 and HIF-1\u03b1\/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats. J Endocrinol Invest. 2019;42(11):1307\u201317. https:\/\/doi.org\/10.1007\/s40618-019-01053-2. (Epub 2019 May 11 PMID: 31079353).","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1880_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.gene.2015.03.063","volume":"565","author":"U Dhamodharan","year":"2015","unstructured":"Dhamodharan U, Viswanathan V, Krishnamoorthy E, Rajaram R, Aravindhan V. Genetic association of IL-6, TNF-\u03b1 and SDF-1 polymorphisms with serum cytokine levels in diabetic foot ulcer. Gene. 2015;565(1):62. https:\/\/doi.org\/10.1016\/j.gene.2015.03.063.","journal-title":"Gene"},{"issue":"Pt B","key":"1880_CR9","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/j.ijbiomac.2018.07.083","volume":"118","author":"V Viswanathan","year":"2018","unstructured":"Viswanathan V, Dhamodharan U, Srinivasan V, Rajaram R, Aravindhan V. Single nucleotide polymorphisms in cytokine\/chemokine genes are associated with severe infection, ulcer grade and amputation in diabetic foot ulcer. Int J Biol Macromol. 2018;118(Pt B):1995\u20132000. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.07.083. (Epub 2018 Jul 14 PMID: 30009916).","journal-title":"Int J Biol Macromol"},{"key":"1880_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.foot.2017.02.001","volume":"30","author":"M Erdogan","year":"2017","unstructured":"Erdogan M, Kulaksizoglu M, Solmaz S, Berdeli A. The relationship of Interleukin-6 -174 G>C gene polymorphism in type 2 diabetic patients with and without diabetic foot ulcers in Turkish population. Foot (Edinb). 2017;30:27\u201331. https:\/\/doi.org\/10.1016\/j.foot.2017.02.001. (Epub 2017 Feb 10 PMID: 28257947).","journal-title":"Foot (Edinb)"},{"issue":"4","key":"1880_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1089\/gtmb.2010.0023","volume":"14","author":"D Corapcioglu","year":"2010","unstructured":"Corapcioglu D, Sahin M, Emral R, Celebi ZK, Sener O, Gedik VT. Association of the G894T polymorphism of the endothelial nitric oxide synthase gene with diabetic foot syndrome foot ulcer, diabetic complications, and comorbid vascular diseases: a Turkish case-control study. Genet Test Mol Biomarkers. 2010;14(4):483\u20138. https:\/\/doi.org\/10.1089\/gtmb.2010.0023. (PMID: 20642368).","journal-title":"Genet Test Mol Biomarkers"},{"issue":"20","key":"1880_CR12","doi-asserted-by":"publisher","first-page":"e10672","DOI":"10.1097\/MD.0000000000010672","volume":"97","author":"X Li","year":"2018","unstructured":"Li X, Lu Y, Wei P. Association between VEGF genetic variants and diabetic foot ulcer in Chinese Han population: a case-control study. Medicine (Baltimore). 2018;97(20):e10672. https:\/\/doi.org\/10.1097\/MD.0000000000010672.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1880_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.diabres.2011.04.016","volume":"93","author":"MM Amoli","year":"2011","unstructured":"Amoli MM, Hasani-Ranjbar S, Roohipour N, Sayahpour FA, Amiri P, Zahedi P, Mehrab-Mohseni M, Heshmat R, Larijani B, Tavakkoly-Bazzaz J. VEGF gene polymorphism association with diabetic foot ulcer. Diabetes Res Clin Pract. 2011;93(2):215\u20139. https:\/\/doi.org\/10.1016\/j.diabres.2011.04.016. (Epub 2011 May 18 PMID: 21596454).","journal-title":"Diabetes Res Clin Pract"},{"key":"1880_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.foot.2018.06.006","volume":"37","author":"M Erdogan","year":"2018","unstructured":"Erdogan M, Kulaksizoglu M, Tetik A, Solmaz S, Kucukaslan AS, Eroglu Z. The relationship of the endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) gene polymorphism in Turkish type 2 diabetic patients with and without diabetic foot ulcers. Foot (Edinb). 2018;37:5\u201310. https:\/\/doi.org\/10.1016\/j.foot.2018.06.006. (Epub 2018 Jun 26 PMID: 30321858).","journal-title":"Foot (Edinb)"},{"issue":"3","key":"1880_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.diabres.2015.05.014","volume":"109","author":"S Pichu","year":"2015","unstructured":"Pichu S, Sathiyamoorthy J, Krishnamoorthy E, Umapathy D, Viswanathan V. Impact of the hypoxia inducible factor-1\u03b1 (HIF-1\u03b1) pro582ser polymorphism and its gene expression on diabetic foot ulcers. Diabetes Res Clin Pract. 2015;109(3):533\u201340. https:\/\/doi.org\/10.1016\/j.diabres.2015.05.014. (Epub 2015 May 22 PMID: 26113285).","journal-title":"Diabetes Res Clin Pract"},{"key":"1880_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.ijbiomac.2018.08.011","volume":"119","author":"S Pichu","year":"2018","unstructured":"Pichu S, Vimalraj S, Sathiyamoorthy J, Viswanathan V. Association of hypoxia inducible factor-1 alpha exon 12 mutation in diabetic patients with and without diabetic foot ulcer. Int J Biol Macromol. 2018;119:833\u20137. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.08.011. (Epub 2018 Aug 4 PMID: 30086330).","journal-title":"Int J Biol Macromol"},{"key":"1880_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2337\/db19-0701","volume":"69","author":"S Hedjazifar","year":"2020","unstructured":"Hedjazifar S, Khatib Shahidi R, Hammarstedt A, Bonnet L, Church C, Boucher J, Bl\u00fcher M, Smith U. The Novel Adipokine Gremlin 1 antagonizes insulin action and is increased in type 2 diabetes and NAFLD\/NASH. Diabetes. 2020;69:331\u201341. https:\/\/doi.org\/10.2337\/db19-0701.","journal-title":"Diabetes"},{"key":"1880_CR18","first-page":"641","volume-title":"The evidence base for diabetes care","author":"GE Reiber","year":"2003","unstructured":"Reiber GE, Ledoux WR. Epidemiology of diabetic foot ulcers and amputa- tions: evidence for prevention. In: Williams R, Herman W, Kinmonth A-L, Wareham NJ, editors. The evidence base for diabetes care. Chichester: Wiley; 2003. p. 641\u201365."},{"key":"1880_CR19","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.2337\/dc05-2031","volume":"29","author":"EJ Boyko","year":"2006","unstructured":"Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical informa- tion: the Seattle diabetic foot study. Diabetes Care. 2006;29:1202\u20137. https:\/\/doi.org\/10.2337\/dc05-2031.","journal-title":"Diabetes Care"},{"issue":"1","key":"1880_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2337\/dc16-2042x","volume":"40","author":"R Pop-Busui","year":"2017","unstructured":"Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic neuropathy: a position statement by the American diabetes association. Diabetes Care. 2017;40(1):136\u201354. https:\/\/doi.org\/10.2337\/dc16-2042x.","journal-title":"Diabetes Care"},{"key":"1880_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.hansur.2019.06.003","volume":"38","author":"M-C Sapa","year":"2019","unstructured":"Sapa M-C, Sagot J-C, Touvenot G, Xavier F, Hidalgo Diaz J-J, Facca S, Zar\u00e9 M, Liverneaux P. Comparison of tactile sensitivity measured with a new digital esthesiometer (Beam Test) relative to Semmes-Weinstein monofilament analog esthesiometer. Hand Surg Rehabil. 2019;38:242\u20135. https:\/\/doi.org\/10.1016\/j.hansur.2019.06.003.","journal-title":"Hand Surg Rehabil"},{"key":"1880_CR22","unstructured":"Supplement 1. American Diabetes Association: clinical practice recom- mendations 2000. Diabetes Care. 2000;23(Suppl 1):1\u2013116."},{"key":"1880_CR23","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u2013104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339.","journal-title":"Eur Heart J"},{"key":"1880_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4158\/ep.18.2.269","volume":"18","author":"PS Jellinger","year":"2012","unstructured":"Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA. AACE task force for management of Dyslipi- demia and prevention of Atherosclerosis American association of clinical Endocrinologists\u2019 guidelines for management of dyslipidemia and prevention of atherosclerosis: executive summary. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2012;18:269\u201393. https:\/\/doi.org\/10.4158\/ep.18.2.269.","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"1880_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, Mchugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"1880_CR26","doi-asserted-by":"publisher","first-page":"910","DOI":"10.2337\/dc14-1741","volume":"38","author":"G Siasos","year":"2015","unstructured":"Siasos G, Gouliopoulos N, Moschos MM, Oikonomou E, Kollia C, Konsola T, Athanasiou D, Siasou G, Mourouzis K, Zisimos K, Papavassiliou AG, Stefanadis C, Tousoulis D. Role of endothelial dysfunction and arterial stiffness in the development of diabetic retinopathy. Diabetes Care. 2015;38(1):910.","journal-title":"Diabetes Care"},{"key":"1880_CR27","volume-title":"The Vascular Endothelium II","author":"P Libby","year":"2006","unstructured":"Libby P, Aikawa M, Jain MK. Vascular endothelium and atherosclerosis. In: Moncada S, Higgs A, editors. The Vascular Endothelium II. Berlin Heidelberg: Springer; 2006."},{"key":"1880_CR28","first-page":"109","volume":"43","author":"S Moncada","year":"1991","unstructured":"Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109\u201342.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1880_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1161\/01.CIR.87.1.86","volume":"87","author":"CB Treasure","year":"1993","unstructured":"Treasure CB, Klein JL, Vita JA, Manoukian SV, Renwick GH, Selwyn AP, Ganz P, Alexander RW. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 1993;87(1):86\u201393.","journal-title":"Circulation"},{"issue":"4","key":"1880_CR30","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1161\/STROKEAHA.108.532853","volume":"40","author":"A Kearney-Schwartz","year":"2009","unstructured":"Kearney-Schwartz A, Rossignol P, Bracard S, Felblinger J, Fay R, Boivin JM, Lecompte T, Lacolley P, Benetos A, Zannad F. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke. 2009;40(4):1229\u201336.","journal-title":"Stroke"},{"issue":"2","key":"1880_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.numecd.2007.02.003","volume":"18","author":"A Tuttolomondo","year":"2008","unstructured":"Tuttolomondo A, Pinto A, Salemi G, Di Raimondo D, Di Sciacca R, Fernandez P, et al. Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome. Nut Metab Cardiovasc Dis. 2008;18(2):152\u20137.","journal-title":"Nut Metab Cardiovasc Dis"},{"key":"1880_CR32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02507","author":"A Tuttolomondo","year":"2019","unstructured":"Tuttolomondo A, Di Raimondo D, Casuccio A, et al. Endothelial function, adipokine serum levels and white matter hyperintesities in subjects with diabetic foot syndrome. J Clin Endocrinol Metab. 2019. https:\/\/doi.org\/10.1210\/jc.2018-02507.","journal-title":"J Clin Endocrinol Metab"},{"key":"1880_CR33","doi-asserted-by":"publisher","first-page":"773797","DOI":"10.3389\/fnagi.2021.773797","volume":"13","author":"Z Teng","year":"2021","unstructured":"Teng Z, Feng J, Qi Q, Dong Y, Xiao Y, Xie X, Meng N, Chen H, Zhang W, Lv P. Long-term use of metformin is associated with reduced risk of cognitive impairment with alleviation of cerebral small vessel disease burden in patients with type 2 diabetes. Front Aging Neurosci. 2021;13:773797. https:\/\/doi.org\/10.3389\/fnagi.2021.773797.","journal-title":"Front Aging Neurosci"},{"issue":"14","key":"1880_CR34","doi-asserted-by":"publisher","first-page":"9901","DOI":"10.1074\/jbc.275.14.9901","volume":"275","author":"R McMahon","year":"2002","unstructured":"McMahon R, Murphy M, Clarkson M, Taal M, Mackenzie HS, Godson C, Martin F, Brady HR. IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. J Biol Chem. 2002;275(14):9901\u20134. https:\/\/doi.org\/10.1074\/jbc.275.14.9901.","journal-title":"J Biol Chem"},{"issue":"3","key":"1880_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2337\/db19-0701","volume":"69","author":"S Hedjazifar","year":"2020","unstructured":"Hedjazifar S, Khatib Shahidi R, Hammarstedt A, Bonnet L, Church C, Boucher J, Bl\u00fcher M, Smith U. The Novel Adipokine Gremlin 1 antagonizes insulin action and is increased in type 2 diabetes and NAFLD\/NASH. Diabetes. 2020;69(3):331\u201341. https:\/\/doi.org\/10.2337\/db19-0701. (Epub 2019 Dec 27 PMID: 31882566).","journal-title":"Diabetes"},{"issue":"18","key":"1880_CR36","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1182\/blood-2010-06-291930","volume":"116","author":"S Mitola","year":"2010","unstructured":"Mitola S, Ravelli C, Moroni E, Salvi V, Leali D, BallmerHofer K, Zammataro L, Presta M. Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2. Blood. 2010;116(18):3677\u201380. https:\/\/doi.org\/10.1182\/blood-2010-06-291930.","journal-title":"Blood"},{"issue":"7","key":"1880_CR37","doi-asserted-by":"publisher","first-page":"e13539","DOI":"10.1111\/eci.13539","volume":"51","author":"II M\u00fcller","year":"2021","unstructured":"M\u00fcller II, Schneider M, M\u00fcller KAL, Lunov O, Borst O, Simmet T, Gawaz M. Protective role of Gremlin-1 in myocardial function. Eur J Clin Invest. 2021;51(7):e13539. https:\/\/doi.org\/10.1111\/eci.13539.","journal-title":"Eur J Clin Invest"},{"issue":"24","key":"1880_CR38","doi-asserted-by":"publisher","first-page":"7917","DOI":"10.1007\/s00018-021-03964-x","volume":"78","author":"S O'Reilly","year":"2021","unstructured":"O\u2019Reilly S. Gremlin: a complex molecule regulating wound healing and fibrosis. Cell Mol Life Sci. 2021;78(24):7917\u201323. https:\/\/doi.org\/10.1007\/s00018-021-03964-x. (Epub 2021 Nov 3 PMID: 34731251).","journal-title":"Cell Mol Life Sci"},{"key":"1880_CR39","unstructured":"Gremlin1 blocks vascular endothelial growth factor signalling in the pulmonary microvascular endothelium; Simon C Rowan, Lucie Piouceau, Joanna Cornwell, Lili Li, Paul McLoughlin UCD School of Medicine and Conway Institute, University College Dublin."},{"key":"1880_CR40","unstructured":"High Plasma Levels of Gremlin-1 and Macrophage Migration Inhibitory Factor, but Not Their Ratio, Indicate an Increased Risk for Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus Karin A.L. Mu \u0308ller, MD; Dominik Rath, MD; Martina Schmid, MD; Heiko Schoenleber, MD; Meinrad Gawaz, MD; Tobias Geisler, MD; Iris I. Mu \u0308ller, MD Department of Cardiology and Circulatory Diseases (K. Mu \u0308ller, Rath, Schmid, Schoenleber, Gawaz, Geisler, I. Muller), Internal Medicine Clinic III, Eberhard Karls University Tu \u0308bingen, Tu \u0308bingen, Germany; La Jolla Institute for Allergy and Immunology (K. Mu \u0308ller), La Jolla, California."},{"key":"1880_CR41","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9286","author":"E Grillo","year":"2016","unstructured":"Grillo E, Ravelli C, Corsini M, et al. Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist. Oncotarget. 2016. https:\/\/doi.org\/10.18632\/oncotarget.9286.","journal-title":"Oncotarget"},{"issue":"1","key":"1880_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emm.2004.1","volume":"36","author":"JW Lee","year":"2004","unstructured":"Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med. 2004;36(1):1\u201312. https:\/\/doi.org\/10.1038\/emm.2004.1. (PMID: 15031665).","journal-title":"Exp Mol Med"},{"issue":"4","key":"1880_CR43","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00125-021-05380-z","volume":"64","author":"SB Catrina","year":"2021","unstructured":"Catrina SB, Zheng X. Hypoxia and hypoxia-inducible factors in diabetes and its complications. Diabetologia. 2021;64(4):709\u201316. https:\/\/doi.org\/10.1007\/s00125-021-05380-z.","journal-title":"Diabetologia"},{"issue":"2","key":"1880_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11154-019-09492-1","volume":"20","author":"M Zubair","year":"2019","unstructured":"Zubair M, Ahmad J. Role of growth factors and cytokines in diabetic foot ulcer healing: a detailed review. Rev Endocr Metab Disord. 2019;20(2):207\u201317. https:\/\/doi.org\/10.1007\/s11154-019-09492-1. (PMID: 30937614).","journal-title":"Rev Endocr Metab Disord"},{"key":"1880_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.archger.2015.08.009","volume":"64","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Liu Z, Wang Y, Wang Z, Shi J, Xie X, Jin L, Chu X, Wang X. C-reactive protein, frailty and overnight hospital admission in elderly individuals: a population-based study. Arch Gerontol Geriatr. 2016;64:1\u20135. https:\/\/doi.org\/10.1016\/j.archger.2015.08.009.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"1880_CR46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/1479164111426162","volume":"9","author":"S Bleda","year":"2012","unstructured":"Bleda S, De Haro J, Varela C, Esparza L, Ferruelo A, Acin F. Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in type II diabetic patients. Diab Vasc Dis Res. 2012;9(1):68\u201374. https:\/\/doi.org\/10.1177\/1479164111426162. (Epub 2011 Nov 7 PMID: 22064697).","journal-title":"Diab Vasc Dis Res"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01880-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01880-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01880-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T10:03:51Z","timestamp":1687773831000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01880-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1880"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01880-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2814460\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"assertion":[{"value":"13 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This protocol study was approved by the Ethics Committee of the Policlinico P. Giaccone Hospital, and all patients provided written informed consent to participate in the study and for the sampling and banking of the biological material. The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki, and written informed consent was obtained from all patients. Ethics approval was obtained using the name of the ethics committee and reference number if appropriate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All enrolled patients (or legal parents or guardians for children) provided consent to publish their individual patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}